 | • レポートコード：QYR9ST03097 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のダビガトラン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ダビガトランの種類別には、タブレット、カプセル、その他に、用途別には、深部静脈血栓症、肺塞栓症、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ダビガトランの種類別市場規模：タブレット、カプセル、その他 ・ダビガトランの用途別市場規模：深部静脈血栓症、肺塞栓症、その他 ・ダビガトランの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Pfizer 、Bayer Healthcare 、GlaxoSmithKline 、Boehringer Ingelheim 、Aspen Holdings 、Bristol-Myers Squibb Company 、Teva Pharmaceutical Industries ・市場規模予測2019-2025：生産量 ・市場規模予測2019-2025：消費量 ・バリューチェーン・販売チャネル分析 ・市場機会・課題分析 ... |
Dabigatran is an innovative anticoagulant, a new generation of thin blood drugs, known as the best drug for prevention of stroke in the past 60 years.In 2018, the global Dabigatran market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dabigatran.
This study researches the market size of Dabigatran, presents the global Dabigatran sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Dabigatran in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Dabigatran for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
This report includes the following manufacturers; we can also add the other companies as you want.
Bayer Healthcare
GlaxoSmithKline
Boehringer Ingelheim
Aspen Holdings
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries
…
Market Segment by Product Type
Tablets
Capsule
Others
Market Segment by Application
Deep Vein Thrombosis
Pulmonary Embolism
Others
Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives are:
To analyze and research the global Dabigatran status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Dabigatran manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dabigatran are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Dabigatran Market Size Growth Rate by Type
1.3.2 Tablets
1.3.3 Capsule
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Dabigatran Market Share by Application (2019-2025)
1.4.2 Deep Vein Thrombosis
1.4.3 Pulmonary Embolism
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dabigatran Market Size
2.1.1 Global Dabigatran Revenue 2014-2025
2.1.2 Global Dabigatran Sales 2014-2025
2.2 Dabigatran Growth Rate by Regions
2.2.1 Global Dabigatran Sales by Regions 2014-2019
2.2.2 Global Dabigatran Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Dabigatran Sales by Manufacturers
3.1.1 Dabigatran Sales by Manufacturers 2014-2019
3.1.2 Dabigatran Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Dabigatran Revenue by Manufacturers (2014-2019)
3.2.2 Dabigatran Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Dabigatran Market Concentration Ratio (CR5 and HHI)
3.3 Dabigatran Price by Manufacturers
3.4 Key Manufacturers Dabigatran Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Dabigatran Market
3.6 Key Manufacturers Dabigatran Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Tablets Sales and Revenue (2014-2019)
4.1.2 Capsule Sales and Revenue (2014-2019)
4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Dabigatran Sales Market Share by Type
4.3 Global Dabigatran Revenue Market Share by Type
4.4 Dabigatran Price by Type
5 Market Size by Application
5.1 Overview
5.1 Global Dabigatran Sales by Application
6 North America
6.1 North America Dabigatran Breakdown Data by Company
6.2 North America Dabigatran Breakdown Data by Type
6.3 North America Dabigatran Breakdown Data by Application
6.4 North America Dabigatran Breakdown Data by Countries
6.4.1 North America Dabigatran Sales by Countries
6.4.2 North America Dabigatran Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Dabigatran Breakdown Data by Company
7.2 Europe Dabigatran Breakdown Data by Type
7.3 Europe Dabigatran Breakdown Data by Application
7.4 Europe Dabigatran Breakdown Data by Countries
7.4.1 Europe Dabigatran Sales by Countries
7.4.2 Europe Dabigatran Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dabigatran Breakdown Data by Company
8.2 Asia Pacific Dabigatran Breakdown Data by Type
8.3 Asia Pacific Dabigatran Breakdown Data by Application
8.4 Asia Pacific Dabigatran Breakdown Data by Regions
8.4.1 Asia Pacific Dabigatran Sales by Countries
8.4.2 Asia Pacific Dabigatran Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Dabigatran Breakdown Data by Company
9.2 Central & South America Dabigatran Breakdown Data by Type
9.3 Central & South America Dabigatran Breakdown Data by Application
9.4 Central & South America Dabigatran Breakdown Data by Countries
9.4.1 Central & South America Dabigatran Sales by Countries
9.4.2 Central & South America Dabigatran Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Dabigatran Breakdown Data by Type
10.2 Middle East and Africa Dabigatran Breakdown Data by Application
10.3 Middle East and Africa Dabigatran Breakdown Data by Countries
10.3.1 Middle East and Africa Dabigatran Sales by Countries
10.3.2 Middle East and Africa Dabigatran Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Dabigatran
11.1.4 Dabigatran Product Introduction
11.1.5 Pfizer Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Dabigatran
11.2.4 Dabigatran Product Introduction
11.2.5 Bayer Healthcare Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Dabigatran
11.3.4 Dabigatran Product Introduction
11.3.5 GlaxoSmithKline Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Dabigatran
11.4.4 Dabigatran Product Introduction
11.4.5 Boehringer Ingelheim Recent Development
11.5 Aspen Holdings
11.5.1 Aspen Holdings Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Dabigatran
11.5.4 Dabigatran Product Introduction
11.5.5 Aspen Holdings Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Dabigatran
11.6.4 Dabigatran Product Introduction
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Dabigatran
11.7.4 Dabigatran Product Introduction
11.7.5 Teva Pharmaceutical Industries Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Dabigatran Sales Channels
12.2.2 Dabigatran Distributors
12.3 Dabigatran Customers
13 Market Forecast
13.1 Global Dabigatran Sales and Revenue Forecast 2019-2025
13.2 Global Dabigatran Sales Forecast by Type
13.3 Global Dabigatran Sales Forecast by Application
13.4 Dabigatran Forecast by Regions
13.4.1 Global Dabigatran Sales Forecast by Regions 2019-2025
13.4.2 Global Dabigatran Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Dabigatran Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Dabigatran Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Dabigatran Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Dabigatran Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Dabigatran Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Dabigatran Product Picture
Table Dabigatran Key Market Segments
Table Major Manufacturers Dabigatran Covered in This Report
Table Global Dabigatran Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Dabigatran Sales Market Shar by Type 2014-2025
Figure Tablets Figures
Table Major Manufacturers of Tablets
Figure Capsule Figures
Table Major Manufacturers of Capsule
Figure Others Figures
Table Major Manufacturers of Others
Table Global Dabigatran Market Share by Application 2019-2025 (K Units)
Figure Deep Vein Thrombosis Use Case
Figure Pulmonary Embolism Use Case
Figure Others Use Case
Figure Dabigatran Report Years Considered
Figure Global Dabigatran Market Size 2014-2025 (Million US$)
Figure Global Dabigatran Sales 2014-2019 (K Units)
Table Global Dabigatran Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Dabigatran Sales by Regions 2014-2019 (K Units)
Table Global Dabigatran Sales Market Share by Regions 2014-2019
Figure Global Dabigatran Sales Market Share by Regions 2014-2019
Figure Global Dabigatran Sales Market Share by Regions in 2018
Table Global Dabigatran Revenue by Regions 2014-2019 (Million US$)
Table Global Dabigatran Revenue Market Share by Regions 2014-2019
Figure Global Dabigatran Revenue Market Share by Regions 2014-2019
Figure Global Dabigatran Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Dabigatran Sales by Manufacturers (2014-2019) (K Units)
Table Global Dabigatran Sales Share by Manufacturers (2014-2019)
Figure Global Dabigatran Sales Share by Manufacturers in 2018
Table Dabigatran Revenue by Manufacturers (2014-2019) (Million USD)
Table Dabigatran Revenue Share by Manufacturers (2014-2019)
Figure Dabigatran Value Share by Manufacturers in 2018
Table Global Dabigatran Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Dabigatran Price (2014-2019) (USD/Ton)
Table Key Manufacturers Dabigatran Plants/Factories Distribution
Table Key Manufacturers Dabigatran Area Served
Table Date of Key Manufacturers Enter into Dabigatran Market
Table Key Manufacturers Dabigatran Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Tablets Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Capsule Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Others Sales an目录输出!D Revenue (2014-2019) (K Units) & (Million US$)
Table Global Dabigatran Sales by Type (2014-2019) (K Units)
Table Global Dabigatran Sales Share by Type (2014-2019)
Figure Global Dabigatran Sales Market Share by Type (2014-2019)
Figure Global Dabigatran Sales Market Share by Type in 2018
Table Global Dabigatran Revenue by Type (2014-2019) (Million US$)
Table Global Dabigatran Revenue Share by Type (2014-2019)
Figure Global Dabigatran Revenue Market Share by Type (2014-2019)
Figure Global Dabigatran Revenue Market Share by Type in 2018
Table Dabigatran Price by Type 2014-2019 (USD/Ton)
Table Global Dabigatran Sales by Application (2014-2019) (K Units)
Table Global Dabigatran Sales Share by Application (2014-2019)
Figure Global Sales Dabigatran Market Share by Application (2014-2019)
Figure Global Sales Dabigatran Market Share by Application in 2018
Figure North America Dabigatran Sales Growth Rate 2014-2019 (K Units)
Figure North America Dabigatran Revenue Growth Rate 2014-2019 (Million US$)
Table North America Dabigatran Sales by Company (2014-2019) (K Units)
Table North America Dabigatran Sales Market Share by Company (2014-2019)
Figure North America Dabigatran Sales Market Share by Company in 2018
Table North America Dabigatran Sales by Type (2014-2019) (K Units)
Table North America Dabigatran Sales Market Share by Type (2014-2019)
Figure North America Dabigatran Market Share by Type in 2018
Table North America Dabigatran Sales by Application (2014-2019) (K Units)
Table North America Dabigatran Sales Market Share by Application (2014-2019)
Figure North America Dabigatran Market Share by Application in 2018
Table North America Dabigatran Sales by Countries (2014-2019) (K Units)
Table North America Dabigatran Sales Market Share by Countries (2014-2019)
Figure North America Dabigatran Sales Market Share by Countries in 2018
Table North America Dabigatran Revenue by Countries (2014-2019) (Million US$)
Table North America Dabigatran Revenue Market Share by Countries (2014-2019)
Figure North America Dabigatran Revenue Market Share by Countries in 2018
Figure United States Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Canada Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Europe Dabigatran Sales Growth Rate 2014-2019 (K Units)
Figure Europe Dabigatran Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Dabigatran Sales by Company (2014-2019) (K Units)
Table Europe Dabigatran Sales Market Share by Company (2014-2019)
Figure Europe Dabigatran Sales Market Share by Company in 2018
Table Europe Dabigatran Sales by Type (2014-2019) (K Units)
Table Europe Dabigatran Sales Market Share by Type (2014-2019)
Figure Europe Dabigatran Sales Market Share by Type in 2018
Table Europe Dabigatran Sales by Application (2014-2019) (K Units)
Table Europe Dabigatran Sales Market Share by Application (2014-2019)
Figure Europe Dabigatran Sales Market Share by Application in 2018
Table Europe Dabigatran Sales by Countries (2014-2019) (K Units)
Table Europe Dabigatran Sales Market Share by Countries (2014-2019)
Figure Europe Dabigatran Sales Market Share by Countries in 2018
Table Europe Dabigatran Revenue by Countries (2014-2019) (Million US$)
Table Europe Dabigatran Revenue Market Share by Countries (2014-2019)
Figure Europe Dabigatran Revenue Market Share by Countries in 2018
Figure Germany Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure France Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure UK Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Italy Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Russia Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Dabigatran Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Dabigatran Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Dabigatran Sales by Regions (2014-2019) (K Units)
Table Asia Pacific Dabigatran Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Dabigatran Sales Market Share by Regions in 2018
Table Asia Pacific Dabigatran Sales by Type (2014-2019) (K Units)
Table Asia Pacific Dabigatran Sales Market Share by Type (2014-2019)
Figure Asia Pacific Dabigatran Market Share by Type in 2018
Table Asia Pacific Dabigatran Sales by Application (2014-2019) (K Units)
Table Asia Pacific Dabigatran Sales Market Share by Application (2014-2019)
Figure Asia Pacific Dabigatran Market Share by Application in 2018
Table Asia Pacific Dabigatran Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Dabigatran Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Dabigatran Sales Market Share by Regions in 2018
Table Asia Pacific Dabigatran Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Dabigatran Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Dabigatran Revenue Market Share by Regions in 2018
Figure China Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure China Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Japan Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Korea Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure India Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure India Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Australia Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Dabigatran Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Dabigatran Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Dabigatran Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Dabigatran Sales by Company (2014-2019) (K Units)
Table Central & South America Dabigatran Sales Market Share by Company (2014-2019)
Figure Central & South America Dabigatran Sales Market Share by Company in 2018
Table Central & South America Dabigatran Sales by Type (2014-2019) (K Units)
Table Central & South America Dabigatran Sales Market Share by Type (2014-2019)
Figure Central & South America Dabigatran Market Share by Type in 2018
Table Central & South America Dabigatran Sales by Application (2014-2019) (K Units)
Table Central & South America Dabigatran Sales Market Share by Application (2014-2019)
Figure Central & South America Dabigatran Market Share by Application in 2018
Table Central & South America Dabigatran Sales by Countries (2014-2019) (K Units)
Table Central & South America Dabigatran Sales Market Share by Countries (2014-2019)
Figure Central & South America Dabigatran Sales Market Share by Countries in 2018
Table Central & South America Dabigatran Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Dabigatran Revenue Market Share by Countries (2014-2019)
Figure Central & South America Dabigatran Revenue Market Share by Countries in 2018
Figure Brazil Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Dabigatran Revenue Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Dabigatran Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Dabigatran Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Dabigatran Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Dabigatran Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Dabigatran Sales Market Share by Type in 2018
Table Middle East and Africa Dabigatran Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Dabigatran Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Dabigatran Sales Market Share by Application in 2018
Table Middle East and Africa Dabigatran Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Dabigatran Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Dabigatran Sales Market Share by Countries in 2018
Table Middle East and Africa Dabigatran Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Dabigatran Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Dabigatran Revenue Market Share by Countries in 2018
Figure GCC Countries Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Dabigatran Revenue Growth Rate (2014-2019) (K Units)
Figure Egypt Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Dabigatran Revenue Growth Rate (2014-2019) (K Units)
Figure South Africa Dabigatran Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Dabigatran Revenue Growth Rate (2014-2019) (K Units)
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Dabigatran Sales (K Units), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Pfizer Dabigatran Sales Growth Rate (2014-2019)
Table Pfizer Dabigatran Sales Market Share in Global Market
Table Pfizer Recent Development
Table Bayer Healthcare Company Details
Table Bayer Healthcare Description and Business Overview
Table Bayer Healthcare Dabigatran Sales (K Units), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Bayer Healthcare Dabigatran Sales Growth Rate (2014-2019)
Table Bayer Healthcare Dabigatran Sales Market Share in Global Market
Table Bayer Healthcare Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Dabigatran Sales (K Units), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table GlaxoSmithKline Dabigatran Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Dabigatran Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Dabigatran Sales (K Units), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Dabigatran Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Dabigatran Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Aspen Holdings Company Details
Table Aspen Holdings Description and Business Overview
Table Aspen Holdings Dabigatran Sales (K Units), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Aspen Holdings Dabigatran Sales Growth Rate (2014-2019)
Table Aspen Holdings Dabigatran Sales Market Share in Global Market
Table Aspen Holdings Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Description and Business Overview
Table Bristol-Myers Squibb Company Dabigatran Sales (K Units), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Dabigatran Sales Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Dabigatran Sales Market Share in Global Market
Table Bristol-Myers Squibb Company Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Description and Business Overview
Table Teva Pharmaceutical Industries Dabigatran Sales (K Units), Revenue (Million US$), Price (USD/Ton) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Dabigatran Sales Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Dabigatran Sales Market Share in Global Market
Table Teva Pharmaceutical Industries Recent Development
Figure Dabigatran Value Chain
Table Dabigatran Distributors List
Table Dabigatran Customers List
Table Global Dabigatran Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Global Dabigatran Revenue Forecast 2019-2025 (Million US$)
Table Global Dabigatran Sales Forecast by Type 2019-2025 (K Units)
Figure Global Dabigatran Sales Forecast by Type 2019-2025 (K Units)
Figure Global Dabigatran Sales Market Share Forecast by Type 2019-2025
Table Global Dabigatran Sales Forecast by Application 2019-2025 (K Units)
Figure Global Dabigatran Sales Forecast by Application 2019-2025 (K Units)
Figure Global Dabigatran Sales Market Share Forecast by Application 2019-2025
Table Global Dabigatran Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Dabigatran Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Dabigatran Sales Market Share Forecast by Regions 2019-2025
Table Global Dabigatran Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Dabigatran Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Dabigatran Revenue Market Share Forecast by Regions 2019-2025
Table North America Dabigatran Sales Forecast by Countries 2019-2025 (K Units)
Table North America Dabigatran Sales Market Share Forecast by Countries 2019-2025
Table North America Dabigatran Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Dabigatran Revenue Market Share Forecast by Countries 2019-2025
Figure United States Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Canada Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Mexico Dabigatran Sales Forecast 2019-2025 (K Units)
Table Europe Dabigatran Sales Forecast by Countries 2019-2025 (K Units)
Table Europe Dabigatran Sales Market Share Forecast by Countries 2019-2025
Table Europe Dabigatran Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Dabigatran Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Dabigatran Sales Forecast 2019-2025 (K Units)
Figure France Dabigatran Sales Forecast 2019-2025 (K Units)
Figure UK Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Italy Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Russia Dabigatran Sales Forecast 2019-2025 (K Units)
Table Asia Pacific Dabigatran Sales Forecast by Regions 2019-2025 (K Units)
Table Asia Pacific Dabigatran Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Dabigatran Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Dabigatran Revenue Market Share Forecast by Regions 2019-2025
Figure China Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Japan Dabigatran Sales Forecast 2019-2025 (K Units)
Figure South Korea Dabigatran Sales Forecast 2019-2025 (K Units)
Figure India Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Australia Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Indonesia Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Thailand Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Malaysia Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Philippines Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Vietnam Dabigatran Sales Forecast 2019-2025 (K Units)
Table Central & South America Dabigatran Sales Forecast by Countries 2019-2025 (K Units)
Table Central & South America Dabigatran Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Dabigatran Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Dabigatran Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Dabigatran Sales Forecast 2019-2025 (K Units)
Table Middle East and Africa Dabigatran Sales Forecast by Regions 2019-2025 (K Units)
Table Middle East and Africa Dabigatran Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Dabigatran Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Dabigatran Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Dabigatran Sales Forecast 2019-2025 (K Units)
Figure GCC Countries Dabigatran Sales Forecast 2019-2025 (K Units)
Figure Egypt Dabigatran Sales Forecast 2019-2025 (K Units)
Figure South Africa Dabigatran Sales Forecast 2019-2025 (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の末梢静脈血栓除去デバイス市場：動向・競争分析 Mechanical thrombectomy devices for acute vices for acute ischaemic strok ischaemic stroke. The Peripheral Venous Thrombectomy Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has be…- 世界の末梢静脈血栓除去デバイス市場：動向・競争分析 Mechanical thrombectomy devices for acute vices for acute ischaemic strok ischaemic stroke. The Peripheral Venous Thrombectomy Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has be…
- 網膜静脈閉塞症治療の世界市場：市場規模・現状・予測 Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization.The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRV…
- 網膜静脈閉塞症治療の世界市場：市場規模・現状・予測 Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization.The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRV…
- 静脈照明器の世界市場：インサイト・予測 The vein illuminator market ecosystem includes major vein illuminator manufacturing companies and start-up companies working on the technology, distributors, and end-user industries that implement these devices.The near infrared illumination (NIR) technology is expected to drive the market owing to …